Meeting
2018 ASCO Quality Care Symposium
Timing of adjuvant chemotherapy administration for early breast cancer.
Authors
Andrew L. Salner
Hartford Hospital, Hartford, CT
Andrew L. Salner, Shelby Smith, Peter Paul Yu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Big Data Studies; Projects Relating to Equity, Value, and Policy
Track
Projects Relating to Equity, Value and Policy,Big Data Studies
Sub Track
Guideline Concordant Care Initiatives
Citation
J Clin Oncol 36, 2018 (suppl 30; abstr 62)
DOI
10.1200/JCO.2018.36.30_suppl.62
Abstract #
62
Poster Bd #
G3
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Relationship between rising bilateral mastectomy rates and increased use of neoadjuvant chemotherapy (NAC) in California, 1998-2012.
First Author: Irene Wapnir
Poster
2024 ASCO Annual Meeting
Predicting completion of endocrine therapy for older patients with early-stage breast cancer.
First Author: Jerome Karp
Poster
2022 ASCO Quality Care Symposium
Improving cardiac monitoring in patients with early-stage breast cancer receiving cardiotoxic chemotherapy in a multidisciplinary cancer center.
First Author: Hannah DeLuna
Poster
2022 ASCO Annual Meeting
Estimating survival benefit of adjuvant chemotherapy in postmenopausal women with pT1-2N0 early-stage breast cancer and Oncotype DX recurrence score > 26: A National Cancer Database (NCDB) analysis.
First Author: Lifen Cao